Indian Court Rules in Favor of Generic Gleevec
Yesterday, the Indian Supreme Court ruled against Novartis’s claims of patent protection for Gleevec, which would have prevented generic drug makers in India from producing and selling the drug, which...
View ArticleDrug Patents Don’t Ensure Innovation
Opinions and perspectives on the Indian Supreme Court’s rejection of Novartis’s patent application for Gleevec/Glivec are plentiful, both in support and against the decision. In the wake of the...
View Article
